Furthermore, a combination of KIM-1 with osteopontin and RBP-4 was shown to be capable of distinguishing CKDu patients from CKD patients with both a sensitivity and specificity of ≥0.93. This evidence concerns the gene HAVCR1 and chronic kidney disease.